Go Deep
SanBio Company Limited
SanBio Company Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,712 | -19.5 | 6.19 | 0.10 | 562.99 |
SanBio Company Limited Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -955,485,000.0 | -836,041,000.0 | -1,128,723,000.0 | -716,644,000.0 |
| EPS | — | -10.7 | — | — |
SanBio Company Limited Revenue & Profit: Last 5 Years
| Line Item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -3,842,612,000.0 | -2,882,885,000.0 | -2,644,332,000.0 | -5,559,584,000.0 | — |
| EPS | -52.5 | -41.9 | -40.5 | -96.0 | — |
SanBio Company Limited Balance Sheet
| Line Item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
| Total Assets | 15,621,539,000.0 | 3,447,339,000.0 | 5,047,291,000.0 | 7,045,114,000.0 | — |
| Total Liabilities | 2,016,872,000.0 | 1,684,417,000.0 | 2,254,893,000.0 | 2,616,205,000.0 | — |
| Total Equity | 13,604,667,000.0 | 1,762,922,000.0 | 2,792,398,000.0 | 4,428,909,000.0 | — |
Owes vs Owns
SanBio Company Limited owed ¥0.14 for every ¥1 it owned in Jul 2026, down from ¥0.37 in Jan 2023.
| Period | Jul 2026 | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.14× | 0.13× | 0.49× | 0.45× | 0.37× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
SanBio Company Limited Assets & Liabilities Breakdown (JPY millions)
What it owns — Jan 2026
Cash & short-term investments 96.6%Other assets 2.7%
How it's funded — Jan 2026
Short-term debt 0.8%Long-term debt 7.1%Payables 1.1%Other liabilities 3.9%Shareholders' equity 87.1%
| Line Item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 15,083.2 | 2,921.4 | 4,454.7 | 6,732.8 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 69.1 | 40.3 | 44.3 | 47.9 |
| Intangible assets | 43.9 | 43.9 | 43.9 | 1.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 425.3 | 441.7 | 504.4 | 263.2 |
| Liabilities & equity | ||||
| Short-term debt | 129.0 | 268.0 | 268.0 | 268.0 |
| Long-term debt | 1,109.7 | 129.0 | 397.0 | 665.0 |
| Payables | 166.7 | 139.4 | 133.9 | 331.7 |
| Other liabilities | 611.5 | 1,148.0 | 1,456.0 | 1,351.5 |
| Shareholders' equity | 13,604.7 | 1,762.9 | 2,792.4 | 4,428.9 |
| Net tangible assets | 13,560.8 | 1,719.0 | 2,748.5 | 4,427.6 |
SanBio Company Limited Cash Flow
| Line Item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
| Operating Activities | -3,760,890,000.0 | -3,603,106,000.0 | -4,765,654,000.0 | -7,434,147,000.0 | — |
| Investing Activities | -231,044,000.0 | -4,267,000.0 | -19,028,000.0 | -10,100,000.0 | — |
| Financing Activities | 15,962,690,000.0 | 2,091,005,000.0 | 2,370,532,000.0 | 9,445,783,000.0 | — |